Summary
IgM antibodies to Epstein-Barr virus (EBV) could be demonstrated by immunofluorescence in the sera of all patients with clinical infectious mononucleosis (IM) and a heterophile antibody titer of ⩾40. The EBV-IgM antibodies were found only over a period of 2 to 3 months after onset of symptoms. Demonstration of IgM antibodies in the sera of patients therefore indicates recent infection and may be useful for diagnosis. The fact that EBV-IgM antibodies can only be demonstrated during a relatively short period supports the assumption that EBV is indeed the etiologic agent of IM.
Similar content being viewed by others
References
Beltran, G., J. W. Northington, E. Leiderman, J. Mogabgab, andW. J. Stuckey: Antibodies to human cell lines with and without ultrastructural evidence for Epstein-Barr virus (EBV) infection in sera from patients with diverse viral illness. Int. J. Cancer7, 375–379 (1971).
Davidsohn, J., andK. Stern: The differential test for infectious monomucleosis. Amer. J. clin. Path.21, 1101–1113 (1951).
Durr, F. E., J. H. Monroe, R. Schmitter, K. A. Traul, andY. Hirshaut: Studies on the infectivity and cytopathology of Epstein-Barr virus in human lympho-blastoid cells. Int. J. Cancer6, 436–449 (1970).
Gerber, P. D., andN. Rosenblum: The incidence of complement-fixing antibodies to herpes simplex and herpes like viruses in man and Rhesus monkeys. Proc. Soc. exp. Biol. (N.Y.)128, 541–546 (1968).
Gsell, H. O.: Epstein-Barr Virus und Mononucleosis infectiosa. Schweiz. med. Wschr.101, 841–848 (1971).
Henle, G., andW. Henle: Immunofluorescence in cells derived from Burkitt's lymphoma. J. Bact.91, 1248–1256 (1966).
Henle, G., W. Henle, andV. Diehl: Relation of Burkitt's tumorassociated herpes-type virus to infectious mononucleosis. Proc. nat. Acad. Sci. (Wash.)59, 91–101 (1968).
Henle, W., G. Henle, B. A. Zajac, G. Pearson, R. Waubke, andM. Scriba: Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science,169, 188–190 (1970).
Hirshaut, Y., P. Glade, P. Glade, L. Octavio, B. D. Vieira, E. Ainbender, B. Dvorak, andL. E. Silzbach: Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection. New Engl. J. Med.283, 502 (1970).
Johansson, B., G. Klein, W. Henle, andG. Henle: Epstein-Barr virus (EBV)-associated antibody pattern in malignant lymphomas and leukemia. Intern. J. Cancer6, 450–462 (1970).
Kanich, R. E., andJ. E. Craighead: Cytomegalovirus infection and Cytomegalic inclusion disease in renal homotransplant recipients. Amer. J. Med.40, 874–882 (1966).
Langenhuysen, A. C., T. H. The, H. O. Nieweg, andJ. G. Kapsenberg: Demonstration of IgM cytomegalovirus-antibodies as an aid to early diagnosis in adults. Clin. exp. Immunol.6, 387–393 (1970).
Niedermann, J. C., R. W. McCollum, G. Henle, andW. Henle: Infectious mononucleosis. J. Amer. med. Ass.203, 205–209 (1968).
Paul, J. R., andW. W. Bunnell: Presence of heterophilic antibodies in infectious mononucleosis. Amer. J. med. Sci.183, 90–104 (1932).
Ritz, E., H. Schmitz, W. Michel undK. Andrassy: Zytomegalie-Virusinfektionen bei hämodialysierten Patienten. Dtsch. med. Wschr.96, 323–326 (1971).
Schmitz, H., undR. Haas: Erfahrungen mit der fluoreszenzserologischen Bestimmung von Antikörpern gegen Cytomegalie-Virus. Z. med. Mikrobiol. Immunol.155, 283–296 (1970).
Schmitz, H., undR. Haas: Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence. Arch. ges. Virusforsch.37, 131 bis 140 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmitz, H., Scherer, M. IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Archiv f Virusforschung 37, 332–339 (1972). https://doi.org/10.1007/BF01241456
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01241456